Clinical Trial Update: Topical Autologous Insulin Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating topical autologous insulin for corneal epithelial defects after ocular surgeries has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Epithelial Defects

Drugs mentioned

• Topical autologous insulin (insulin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Corneal Epithelial Defects After Ocular Surgeries | Phase 1 | Status: COMPLETED